We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current UTHR market cap is 14.31B. The company's latest EPS is USD 22.2023 and P/E is 14.54.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 506.9M | 596.5M | 609.4M | 614.7M | 677.7M |
| Operating Income | 284.4M | 313.4M | 327M | 260.1M | 356.3M |
| Net Income | 240.9M | 259.2M | 267.6M | 217.1M | 306.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.45B | 1.48B | 1.69B | 1.94B | 2.33B |
| Operating Income | -187.6M | 593.6M | 442.5M | 979.7M | 1.18B |
| Net Income | -104.5M | 514.8M | 362.4M | 727.3M | 984.8M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.35B | 6.68B | 7.02B | 7.17B | 6.5B |
| Total Liabilities | 1.22B | 1.27B | 1.31B | 1.18B | 1.16B |
| Total Equity | 5.12B | 5.41B | 5.71B | 5.98B | 5.34B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.91B | 4.62B | 5.17B | 6.04B | 7.17B |
| Total Liabilities | 1.13B | 1.22B | 1.21B | 1.25B | 1.18B |
| Total Equity | 2.78B | 3.4B | 3.96B | 4.8B | 5.98B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 374.8M | 481.1M | 827.3M | 978M | 376.5M |
| Investing | -221.1M | -448.3M | -761.7M | -719.6M | 735.3M |
| Financing | 48.6M | 73.3M | 80.9M | -11.9M | -1.07B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -206.6M | 755.7M | 598.2M | 802.5M | 978M |
| Investing | -335.4M | -738.5M | -486.9M | -811.5M | -719.6M |
| Financing | 611.2M | -16.9M | 44.8M | 75.4M | -11.9M |
| Market Cap | 14.31B |
| Price to Earnings Ratio | 14.54 |
| Price to Sales Ratio | 6.15 |
| Price to Cash Ratio | 11.86 |
| Price to Book Ratio | 2.39 |
| Dividend Yield | - |
| Shares Outstanding | 44.36M |
| Average Volume (1 week) | 371.21k |
| Average Volume (1 Month) | 634.07k |
| 52 Week Change | 44.16% |
| 52 Week High | 326.46 |
| 52 Week Low | 208.6249 |
| Spread (Intraday) | 1.32 (0.41%) |
| Company Name | United Therapeutics Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.unither.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
